SCHEMBL6537481

SCHEMBL6537481

O=C(O)Cc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.46
PLEC Q15149 1/20 0.46
KDR P35968 5/20 0.46
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
JAK2 O60674 3/20 0.43
TYK2 P29597 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
JAK1 P23458 2/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
TP53 P04637 1/20 0.42
GAA P10253 1/20 0.42
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
SLC16A3 O15427 1/20 0.41
CDK1 P06493 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538050 0.90 KDR (0.46) MAPTPLECKDRMEN1KMT2A
SCHEMBL6537950 0.88 KDR (0.48) MAPTPLECKDRMEN1KMT2A
SCHEMBL6537320 0.87 KDR (0.47) MAPTPLECKDRMEN1KMT2A
SCHEMBL8471791 0.86 MAOB (0.47) MAPTPLECKDRMEN1KMT2A
SCHEMBL6537616 0.84 KDR (0.46) MAPTPLECKDRMEN1KMT2A
SCHEMBL6538309 0.84 PTGES (0.48) MAPTPLECKDRMEN1KMT2A
SCHEMBL6537645 0.82 KDR (0.43) MAPTPLECKDRMEN1KMT2A
SCHEMBL6538256 0.82 MAPT (0.52) MAPTPLECKDRMEN1KMT2A
SCHEMBL6537852 0.81 KDR (0.48) MAPTPLECKDRMEN1KMT2A
SCHEMBL6537425 0.81 KDR (0.51) MAPTPLECKDRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed